iNova Pharmaceuticals Executive and Leadership Team

William Foo, the Group Chief Financial Officer at iNova Pharmaceuticals, manages the company's financial operations and strategic fiscal planning. Foo directs all financial reporting, budgeting, forecasting, and investment activities, ensuring robust financial health and sustainable growth. This critical position involves overseeing treasury functions, managing capital allocation, and driving financial performance across all operating regions. By providing strategic financial insights, William Foo supports executive decision-making and guides the company's expansion efforts in Asia, Australia and New Zealand, and Africa. Foo's expertise is essential for maintaining investor confidence and securing the financial resources needed to develop and market iNova Pharmaceuticals' extensive range of health products. The Group Chief Financial Officer ensures compliance with all financial regulations and optimizes financial structures to support the company's long-term objectives.

Paul Smith, the Chief Operating Officer at iNova Pharmaceuticals, directs the company's day-to-day operational activities and ensures the efficient execution of its global strategy. Overseeing all aspects of production, supply chain management, and operational infrastructure, Smith drives process improvements and optimizes resource allocation across the organization. This leadership role involves close collaboration with regional presidents and the finance group to align operational capabilities with market demands and growth objectives. By focusing on operational excellence, Paul Smith ensures the reliable delivery of iNova Pharmaceuticals' diverse portfolio of prescription medicines and consumer health products to markets throughout Asia, Australia and New Zealand, and Africa. Smith's strategic oversight guarantees that manufacturing processes meet stringent quality standards and regulatory requirements, supporting the company's mission to enhance health and well-being.

Johan Rempel, the President at iNova Pharmaceuticals, provides overarching leadership and strategic direction for key business segments. Rempel guides the company's vision and ensures alignment across various departments, fostering a culture of innovation and operational excellence. This executive role involves significant engagement with the board and senior leadership to shape corporate strategy and drive market expansion. Johan Rempel's leadership is crucial for navigating complex market dynamics and capitalizing on emerging opportunities within the pharmaceutical and consumer health sectors. The President's influence extends to overseeing major initiatives that support iNova Pharmaceuticals' mission to improve global health outcomes. Rempel's strategic oversight ensures the company remains at the forefront of its industry.

Sacha Ernst, the President (Asia) at iNova Pharmaceuticals, directs the company's strategic operations and market development throughout the Asian region. Ernst is responsible for driving revenue growth, expanding market share, and ensuring the successful launch and distribution of iNova Pharmaceuticals' product portfolio within diverse Asian markets. This leadership position involves managing regional teams, fostering key partnerships, and adapting global strategies to meet local consumer needs and regulatory landscapes. Sacha Ernst's focus on operational efficiency and market responsiveness is critical for maximizing the impact of the company's prescription medicines and consumer health products. The President (Asia) plays a vital role in strengthening iNova Pharmaceuticals' presence and commitment to improving health outcomes across this significant geographical area.

Andrew Jenkin, the President, , Zealand (Canada, Australia) at iNova Pharmaceuticals, oversees the strategic direction and commercial performance across Canada, Australia, and New Zealand. Jenkin drives market penetration and revenue generation for iNova Pharmaceuticals' extensive range of prescription medicines and consumer health products within these key territories. This executive role involves leading regional management teams, optimizing sales and marketing efforts, and ensuring compliance with local regulations. Andrew Jenkin's leadership focuses on enhancing the company's brand presence and accessibility to healthcare providers and consumers. By championing strategic initiatives, Jenkin contributes significantly to iNova Pharmaceuticals' mission of improving health and well-being across these important global markets. The President, , Zealand (Canada, Australia) ensures cohesive operations across distinct geographical areas.

Omar Mahmoud, the Chief Marketing Officer, Commercial Quality, MENA at iNova Pharmaceuticals, spearheads marketing initiatives and ensures commercial quality standards within the Middle East and North Africa region. Mahmoud develops and executes comprehensive marketing strategies designed to enhance brand visibility and drive product adoption for iNova Pharmaceuticals' prescription medicines and consumer health products. This role encompasses market analysis, campaign management, and the cultivation of strong customer relationships. Omar Mahmoud also champions commercial quality, ensuring all marketing and sales activities adhere to the highest ethical and regulatory standards. By focusing on market penetration and brand integrity in the MENA region, Mahmoud directly contributes to the company's overall growth and reputation. The Chief Marketing Officer, Commercial Quality, MENA plays a pivotal part in adapting global strategies to local market nuances.